Search Results - "JUTTMANN, J. R"

Refine Results
  1. 1
  2. 2
  3. 3

    Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis by Thiébaud, D, Burckhardt, P, Kriegbaum, H, Huss, H, Mulder, H, Juttmann, J R, Schöter, K H

    Published in The American journal of medicine (01-10-1997)
    “…Oral treatment of osteoporosis with bisphosphonates relies on compliance, the absorption being low and suppressed by simultaneous food intake. Intravenous (IV)…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Bone Marrow Edema in Osteoporotic Vertebral Compression Fractures after Percutaneous Vertebroplasty and Relation with Clinical Outcome by Voormolen, M.H.J, van Rooij, W.J, van der Graaf, Y, Lohle, P.N.M, Lampmann, L.E.H, Juttmann, J.R, Sluzewski, M

    Published in American Journal of Neuroradiology (01-05-2006)
    “…Little is known about the evolution of bone marrow edema (BME) in osteoporotic vertebral compression fractures (VCF) after percutaneous vertebroplasty (PV) or…”
    Get full text
    Journal Article
  6. 6

    Pain Response in the First Trimester after Percutaneous Vertebroplasty in Patients with Osteoporotic Vertebral Compression Fractures with or without Bone Marrow Edema by Voormolen, M.H.J, van Rooij, W.J, Sluzewski, M, van der Graaf, Y, Lampmann, L.E.H, Lohle, P.N.M, Juttmann, J.R

    Published in American Journal of Neuroradiology (01-08-2006)
    “…Presence of bone marrow edema (BME) in osteoporotic vertebral compression fractures (VCF) detected by MR imaging as selection criterion for percutaneous…”
    Get full text
    Journal Article
  7. 7

    Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure by Hamdy, Neveen A T, Kanis, John A, Beneton, Monique N C, Brown, Colin B, Juttmann, Job R, Jordans, Johannes G M, Josse, Sylvie, Meyrier, Alain, Lins, Robert L, Fairey, Ian T

    Published in BMJ (11-02-1995)
    “…Abstract Objective: To determine whether alfacalcidol—used in management of overt renal bone disease—may safely prevent renal bone disease when used earlier in…”
    Get full text
    Journal Article
  8. 8

    Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis by HEIJCKMANN, A. C, JUTTMANN, J. R, WOLFFENBUTTEL, B. H. R

    Published in Netherlands journal of medicine (01-09-2002)
    “…There are several options for the treatment of osteoporosis in postmenopausal women. One of the options is treatment with bisphosphonates, which are very…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Clinical experience with the combined use of lopinavir/ritonavir and rifampicin by L'HOMME, Rafaëlla F. A, NIJLAND, Hanneke M. J, GRAS, Luuk, AARNOUTSE, Rob E, VAN CREVEL, Reinout, BOEREE, Martin, BRINKMAN, Kees, PRINS, Jan M, JUTTMANN, Job R, BURGER, David M

    Published in AIDS (London) (27-04-2009)
    “…Thirty-four patients treated concomitantly with lopinavir/ritonavir and rifampicin were evaluated. Overall, only 15% used the recommended increased dose of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study) by STUART, J. W. T. C, SCHUURMAN, R, BRAVENBOER, B, HAMANN, D, BOUCHER, C. A. B, BORLEFFS, J. C. C, BURGER, D. M, KOOPMANS, P. P, SPRENGER, H. G, JUTTMANN, J. R, RICHTER, C, MEENHORST, P. L, HOETELMANS, R. M. W, KROON, F. P

    Published in AIDS (London) (07-05-1999)
    “…To compare efficacy and tolerability of saquinavir soft gelatin capsule (SQV-SGC) formulation and indinavir, both given as part of a triple drug regimen…”
    Get full text
    Journal Article
  13. 13

    Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension by Juttmann, J R, de Vries Robles, P, Venuti, R P

    “…A single-center, randomized, double-blind study in 14 hypertensive patients was conducted to investigate the acute and short-term safety of the addition of…”
    Get more information
    Journal Article
  14. 14

    Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants by VAN ROON, E. N, VERZIJL, J. M, JUTTMANN, J. R, LENDERINK, A. W, BLANS, M. J, EGBERTS, A. C. G

    “…To determine the incidence and determinants for discontinuation of initial highly active antiretroviral therapy (HAART). In this retrospective follow-up study…”
    Get full text
    Journal Article
  15. 15

    A testicular tumour in the left adnex. The persistent mullerian duct syndrome with testicular malignancy by van Laarhoven, C J, Juttmann, J R, Pijpers, P M, Roukema, J A

    Published in European journal of surgical oncology (01-02-1991)
    “…Cryptorchidism is known to increase the incidence of testicular malignant tumours. In this report a patient is described with the Mullerian duct syndrome in…”
    Get more information
    Journal Article
  16. 16

    Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

    Published in The Lancet (British edition) (01-07-2010)
    “…Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 cell counts have higher mortality than…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects by Juttmann, J R, Visser, T J, Buurman, C, de Kam, E, Birkenhäger, J C

    “…Serum concentrations of 25-hydroxycholecalciferol (25-OHD), 24,25-dihydroxycholecalciferol (24,25-(OH)2D), and 1,25-dihydroxycholecalciferol (1,25-(OH)2D) were…”
    Get full text
    Journal Article
  20. 20